Dr. Yeang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCSD Rancho Bernado
16950 Via Tazon
San Diego, CA 92127Phone+1 800-926-8273
Clinical Expertise
- Atherosclerosis, Preventive cardiology, Lipid metabolism disorders, Lipoprotein disorders, Lipoprotein(a)
Education & Training
- University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 2014 - 2019
- UC San Diego Medical Center - HillcrestPost-Doctoral Fellowship, 2014 - 2019
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2012 - 2014
- State University of New York Downstate Medical Center College of MedicineClass of 2012
Certifications & Licensure
- CA State Medical License 2013 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- The Effects of Colchicine on Lipoprotein(a) and Oxidized Phospholipid Associated Cardiovascular Disease Risk.Niekbachsh Mohammadnia, Amber van Broekhoven, Willem A Bax, John W Eikelboom, Arend Mosterd
European Journal of Preventive Cardiology. 2024-10-30 - Isolation and Cryopreservation of Highly Viable Human Peripheral Blood Mononuclear Cells From Whole Blood: A Guide for Beginners.Brian Dinh, Marten A Hoeksema, Nathanael J Spann, Jacob Rendler, Isidoro Cobo
Journal of Visualized Experiments. 2024-10-25 - 1 citationsIn Search of an Accurate Measurement of LDL-C: Correction for Lp(a)-Cholesterol to Predict Clinical Outcomes.Sotirios Tsimikas, Calvin Yeang, Florian Kronenberg
Journal of the American College of Cardiology. 2024-07-09
Lectures
- Lp(a)-Cholesterol and True LDL-Cholesterol: Implications for Refining CVD Risk Attributed to LDL and Lp(a)Lipoprotein(a) Symposium, EAS endorsed satellite meeting - 5/24/2019
- The Role of Lp(a) in Calcific Aortic Valve Disease: Clinical and Basic Research EvidenceHeart Valve Society - 4/12/2018
Authored Content
- The Role of Lipoprotein(A) in Calcific AV Disease and Insights into Its Medical TherapiesApril 2020
- The Role of Lipoprotein(A) in Calcific AV Disease and Insights into Its Medical TherapiesApril 2020
- PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes with a Human Antibody Detects Clinically Relevant AtherothrombosisJanuary 2018
- PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes with a Human Antibody Detects Clinically Relevant AtherothrombosisJanuary 2018
- Join now to see all
Grant Support
- Defining the Role of Lipoprotein(a) and its Oxidized Phospholipids in the Development and Progression of Calcific Aortic Valve Disease Using Unique Transgenic Mouse ModelsNIH/NHLBI2020–2025
Professional Memberships
- Member
- Member
- European Atherosclerosis SocietyMember
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: